Target intelligence / Profile preview

ZFP36 ring finger protein like 2 (ZFP36L2)

Target
ZFP36L2
Molecular classification
RNA-binding protein, Zinc finger protein, Post-transcriptional regulator, Transcription factor (putative)
01

Overview

ZFP36 ring finger protein like 2 (ZFP36L2) is an RNA-binding protein belonging to the CCCH-type zinc finger (TIS11) family, characterized by a tandem zinc finger motif that recognizes AU-rich elements in the 3'-untranslated regions (3'-UTRs) of target mRNAs[2][7]. It promotes deadenylation and decay of these mRNAs, thereby modulating gene expression post-transcriptionally. This activity positions ZFP36L2 as a key regulator of cell cycle progression, apoptosis, and immune cell differentiation. Its functions are implicated in tumorigenesis, immune response, and hematopoiesis. Loss of function or dysregulation is linked to various cancers, autoimmune disorders, and fertility issues. ZFP36L2 is also under investigation as a prognostic and immunotherapy biomarker in lower-grade glioma, with its expression associated with immune infiltration and response to immune checkpoint blockade. Despite its clear biological significance, it is not currently targeted directly by approved therapeutics, but modulation of its pathway is of considerable research interest[2][5][7][8].

Other names
TIS11DERF2RNF162CBRF2Butyrate response factor 2Zinc finger protein 36, C3H type-like 2mRNA decay activator protein ZFP36L2TPA-induced sequence 11dzfp36l2-a, zfp36l2-b (in model organisms)XC3H-3, c3h-3 (in model organisms)
02

Mechanism of action

No drugs with direct, characterized mechanisms of action on ZFP36L2 are currently available. Experimental approaches that modulate its activity typically involve gene expression manipulation (e.g., enforced expression, knockdown) or affect pathways controlling its expression (e.g., stress, cytokines, growth factors)[2][8].

03

Biological functions

mRNA decay (ARE-mediated mRNA degradation)Post-transcriptional gene regulationCell cycle regulationApoptosisImmune response modulationNegative regulation of cell proliferationRegulation of oocyte maturation and ovulationRegulation of T and B cell differentiation and quiescence
04

Disease associations

Cancer (including pancreatic ductal adenocarcinoma, gastric cancer, glioblastoma, T-cell leukemia, and lower-grade glioma)InflammationImmune dysregulation/autoimmunityFemale infertility (oocyte/zygote/embryo maturation arrest)Hematological malignanciesNeurodevelopmental roles (mature peripheral neuron integrity)
05

Safety considerations

Therapeutic targeting might risk interfering broadly with mRNA stability, leading to off-target effects on immune homeostasis, hematopoiesis, and fertility[8][7].Regulation of immune response: loss can provoke autoimmunity or failure of T cell quiescence[8].Developmental and reproductive system risks: Loss of function causes oocyte or embryo maturation arrest, female infertility, hematological abnormalities, and impaired neuron maturation[7].
06

Interacting drugs

Currently, no specific drugs are known to directly target ZFP36L2 in clinical use. Its expression or function may be influenced indirectly by agents affecting upstream regulatory pathways (e.g., p53, certain cytokines, or immunomodulatory drugs)[5][7][8].
07

Biomarkers

ZFP36L2 expression is a prognostic biomarker for poor clinical outcomes in lower-grade glioma[5].ZFP36L2 methylation status may serve as a biomarker for prognosis.Expression correlates with immune infiltration and PD-L1 expression in glioma, suggesting a predictive biomarker role for immunotherapy responsiveness[5].

Beyond the preview

Go deeper on ZFP36 ring finger protein like 2 (ZFP36L2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZFP36 ring finger protein like 2 (ZFP36L2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call